Sales and Market Access

The Sales and Market Access team at Fennec Pharmaceuticals is responsible for driving the commercial strategy and securing market adoption of PEDMARK™, a unique formulation of Sodium Thiosulfate designed to reduce cisplatin-induced hearing loss. This team ensures broad access to the treatment through strategic partnerships, sales efforts, and by navigating regulatory and reimbursement landscapes.